To facilitate countries to estimate the long-term health benefits and cost-effectiveness of one-dose HPV vaccination, an HPV vaccine impact and cost-effectiveness tool (PRIME tool) has been updated. WHO HQ will develop the user interface for this new PRIME tool. You are invited to spend five minutes to complete a survey designed to help understand who the potential users are and how they intend to use the tool. WHO can then design the most useful and informative aid for decision-makers.
Your response by February 9, 2024, would be greatly appreciated.
Go to survey
Please contact yeungh@who.int if you have questions regarding this survey